ORGANIZING PNEUMONIA: AN ETIOLOGICAL DILEMMA IN PATIENTS ON RITUXIMAB FOR TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER

被引：0
|
作者：
Freeman, Howard
Zuckerman, Omry
O'Sullivan, Mary
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.3338
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5626A / 5627A
页数：2
相关论文
共 50 条
  • [11] Low-dosage of rituximab in Chinese patients with neuromyelitis optica spectrum disorder
    Lin, Jie
    Li, Xiang
    Xue, Binbin
    Tong, Qiuling
    Chen, Zhibo
    Zhu, Weiqian
    Li, Jia
    Xia, Junhui
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 317 : 1 - 4
  • [12] Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
    Nosadini, Margherita
    Alper, Gulay
    Riney, Catherine J.
    Benson, Leslie A.
    Mohammad, Shekeeb S.
    Ramanathan, Sudarshini
    Nolan, Melinda
    Appleton, Richard
    Leventer, Richard J.
    Deiva, Kumaran
    Brilot, Fabienne
    Gorman, Mark P.
    Waldman, Amy T.
    Banwell, Brenda
    Dale, Russell C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [13] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
  • [14] A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
    Kim, Su-Hyun
    Huh, So-Young
    Lee, Sun Ju
    Joung, Aeran
    Kim, Ho Jin
    JAMA NEUROLOGY, 2013, 70 (09) : 1110 - 1117
  • [15] Rituximab maintenance treatment outcomes in patients with relapsing neuromyelitis optica spectrum disorder: a monocentric retrospective analysis
    Xiao, Lianchen
    Huang, Yanning
    Sun, Hui
    Gao, Sai
    Huang, Dehui
    Wu, Lei
    ACTA NEUROLOGICA BELGICA, 2024, 124 (06) : 1847 - 1854
  • [16] Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder
    Hayes, Michael T. G.
    Adam, Robert J.
    McCombe, Pamela A.
    Walsh, Michael
    Blum, Stefan
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
  • [17] Inebilizumab for treatment of neuromyelitis optica spectrum disorder
    Tullman, Mark J.
    Zabeti, Aram
    Vuocolo, Scott
    Dinh, Quinn
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (05) : 341 - 352
  • [18] Satralizumab in the treatment of neuromyelitis optica spectrum disorder
    Duchow, Ankelien
    Bellmann-Strobl, Judith
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 49 - 59
  • [19] Cyclophosphamide treatment in Neuromyelitis Optica Spectrum Disorder
    Gulluoglu, H.
    Uysal, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 798 - 798
  • [20] Eculizumab in the treatment of neuromyelitis optica spectrum disorder
    Nabizadeh, Fardin
    Moghadasi, Abdorreza Naser
    CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (02): : 140 - 143
12345